Back
Open Access

Addition of sodium-glucose cotransporter-2 inhibitors on steroidal mineralocorticoid receptor antagonists eliminates hyperkalemia risk in diabetic heart failure patients with chronic kidney disease

Session: Congestion, SGLT2 inhibitors and novel therapies
Topic: Pharmacotherapy
Speaker: Assistant Professor A. Sahin (Sivas, TR)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Anil Sahin

Cumhuriyet University, Sivas (Türkiye)
0 follower

5 more presentations in this session

Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalaemia a barrier?

Speaker: Professor E. Kelepouris (Philadelphia, US)

Access
Abstract
Like
Thumbnail

Factors influencing the up-titration to 10 mg target dose of vericiguat: data from a large observational cohort-study in the US.

Speaker: Doctor A. Michel (Basel, CH)

Access
Abstract
Like
Thumbnail

Safety and efficacy of sodium-glucose cotransporter 2 inhibitors in patients with cardiac amyloidosis: a meta-analysis

Speaker: Professor D. D'Amario (Novara, IT)

Access
Abstract
Like
Thumbnail

Introduction and optimization of the guideline-directed medical therapy in patients hospitalized for acute heart failure (OPTICARD)

Speaker: Doctor G. Baudry (Nancy, FR)

Access
Abstract
Like
Thumbnail

The impact on CD146 congestion biomarker by early adding SGLT2i dapaglifozin to intravenous loop diuretic in patients with acute heart failure

Speaker: Doctor I. Lala (Arad, RO)

Access
Abstract
Like
Thumbnail

Access the full session

Congestion, SGLT2 inhibitors and novel therapies

Speakers: Assistant Professor A. Sahin, Professor E. Kelepouris, Doctor A. Michel, Professor D. D'Amario, Doctor G. Baudry...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources